FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2149331409> ?p ?o ?g. }

• W2149331409 endingPage "278" @default.
• W2149331409 startingPage "268" @default.
• W2149331409 abstract "Aliskiren, a direct renin inhibitor, is effective for reducing blood pressure (BP) in patients with hypertension when combined with amlodipine or hydrochlorothiazide (HCTZ). However, the efficacy and tolerability of the 2 combinations are unclear. We performed a meta-analysis of randomized controlled trials of aliskiren/amlodpine and aliskiren/HCTZ for hypertension. The Cochrane Central Register of Controlled Trials, MEDLINE, Embase, and the Novartis clinical trial database were searched through December 2012 for reports of randomized controlled trials of aliskiren/amlodpine and aliskiren/HCTZ vs. monotherapy in patients with hypertension. The main outcome measures were reduction in systolic BP and diastolic BP from baseline and rates of therapeutic response and BP control. Tolerance of aliskiren/amlodipine and aliskiren/HCTZ was also analyzed. Outcomes were initially pooled by standard random-effects methods, producing a weighted mean difference (WMD) or risk ratio (RR) and 95% confidence intervals (CIs). The pooled estimates were then used for adjusted indirect comparisons. We selected 19 reports of trials involving 13,614 participants. Aliskiren/amlodpine and aliskiren/HCTZ were more effective than monotherapy in controlling BP. Aliskiren/amlodipine was significantly more effective than aliskiren/HCTZ in reducing systolic BP (WMD = −3.36mm Hg; 95% CI = −4.64 to 2.07mm Hg) and diastolic BP (WMD = −3.49mm Hg; 95% CI = −4.34 to 2.63mm Hg). As compared with aliskiren/HCTZ, alikiren/amlodipine was associated with higher rate of therapeutic response (RR = 1.23; 95% CI = 1.14–1.33) and BP control (RR = 1.24; 95% CI = 1.11–1.39). Number of adverse events and withdrawals due to adverse events were similar with aliskiren/amlodipine and aliskiren/HCTZ. BP control is better with aliskiren combined with amlodipine or HCTZ than with monotherapy, with aliskiren/amlodipine being more effective than aliskiren/HCTZ." @default.
• W2149331409 created "2016-06-24" @default.
• W2149331409 creator A5008893447 @default.
• W2149331409 creator A5015846827 @default.
• W2149331409 creator A5016356184 @default.
• W2149331409 creator A5037812496 @default.
• W2149331409 creator A5041882733 @default.
• W2149331409 creator A5047377131 @default.
• W2149331409 creator A5072711933 @default.
• W2149331409 creator A5074238628 @default.
• W2149331409 date "2013-12-04" @default.
• W2149331409 modified "2023-09-27" @default.
• W2149331409 title "Aliskiren/Amlodipine vs. Aliskiren/Hydrochlorothiazide in Hypertension: Indirect Meta-Analysis of Trials Comparing the Two Combinations vs. Monotherapy" @default.
• W2149331409 cites W1539711020 @default.
• W2149331409 cites W1540223602 @default.
• W2149331409 cites W1724892122 @default.
• W2149331409 cites W1931387313 @default.
• W2149331409 cites W1971391209 @default.
• W2149331409 cites W1986215651 @default.
• W2149331409 cites W2005947177 @default.
• W2149331409 cites W2007872832 @default.
• W2149331409 cites W2010976741 @default.
• W2149331409 cites W2016342558 @default.
• W2149331409 cites W2027617419 @default.
• W2149331409 cites W2041418410 @default.
• W2149331409 cites W2042377649 @default.
• W2149331409 cites W2060379095 @default.
• W2149331409 cites W2067519483 @default.
• W2149331409 cites W2086338296 @default.
• W2149331409 cites W2092997095 @default.
• W2149331409 cites W2094625675 @default.
• W2149331409 cites W2095182966 @default.
• W2149331409 cites W2096740080 @default.
• W2149331409 cites W2103886408 @default.
• W2149331409 cites W2106982105 @default.
• W2149331409 cites W2110880027 @default.
• W2149331409 cites W2115479774 @default.
• W2149331409 cites W2122920471 @default.
• W2149331409 cites W2139480984 @default.
• W2149331409 cites W2143954917 @default.
• W2149331409 cites W2144083185 @default.
• W2149331409 cites W2145461177 @default.
• W2149331409 cites W2159342622 @default.
• W2149331409 cites W2161490522 @default.
• W2149331409 cites W2318174853 @default.
• W2149331409 cites W75245760 @default.
• W2149331409 doi "https://doi.org/10.1093/ajh/hpt210" @default.
• W2149331409 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24304656" @default.
• W2149331409 hasPublicationYear "2013" @default.
• W2149331409 type Work @default.
• W2149331409 sameAs 2149331409 @default.
• W2149331409 citedByCount "9" @default.
• W2149331409 countsByYear W21493314092014 @default.
• W2149331409 countsByYear W21493314092015 @default.
• W2149331409 countsByYear W21493314092016 @default.
• W2149331409 countsByYear W21493314092017 @default.
• W2149331409 countsByYear W21493314092020 @default.
• W2149331409 countsByYear W21493314092021 @default.
• W2149331409 crossrefType "journal-article" @default.
• W2149331409 hasAuthorship W2149331409A5008893447 @default.
• W2149331409 hasAuthorship W2149331409A5015846827 @default.
• W2149331409 hasAuthorship W2149331409A5016356184 @default.
• W2149331409 hasAuthorship W2149331409A5037812496 @default.
• W2149331409 hasAuthorship W2149331409A5041882733 @default.
• W2149331409 hasAuthorship W2149331409A5047377131 @default.
• W2149331409 hasAuthorship W2149331409A5072711933 @default.
• W2149331409 hasAuthorship W2149331409A5074238628 @default.
• W2149331409 hasBestOaLocation W21493314091 @default.
• W2149331409 hasConcept C126322002 @default.
• W2149331409 hasConcept C126894567 @default.
• W2149331409 hasConcept C164705383 @default.
• W2149331409 hasConcept C168563851 @default.
• W2149331409 hasConcept C197934379 @default.
• W2149331409 hasConcept C198710026 @default.
• W2149331409 hasConcept C2778375690 @default.
• W2149331409 hasConcept C2779646130 @default.
• W2149331409 hasConcept C2779838083 @default.
• W2149331409 hasConcept C2780361556 @default.
• W2149331409 hasConcept C71924100 @default.
• W2149331409 hasConcept C84393581 @default.
• W2149331409 hasConcept C98274493 @default.
• W2149331409 hasConceptScore W2149331409C126322002 @default.
• W2149331409 hasConceptScore W2149331409C126894567 @default.
• W2149331409 hasConceptScore W2149331409C164705383 @default.
• W2149331409 hasConceptScore W2149331409C168563851 @default.
• W2149331409 hasConceptScore W2149331409C197934379 @default.
• W2149331409 hasConceptScore W2149331409C198710026 @default.
• W2149331409 hasConceptScore W2149331409C2778375690 @default.
• W2149331409 hasConceptScore W2149331409C2779646130 @default.
• W2149331409 hasConceptScore W2149331409C2779838083 @default.
• W2149331409 hasConceptScore W2149331409C2780361556 @default.
• W2149331409 hasConceptScore W2149331409C71924100 @default.
• W2149331409 hasConceptScore W2149331409C84393581 @default.
• W2149331409 hasConceptScore W2149331409C98274493 @default.
• W2149331409 hasIssue "2" @default.
• W2149331409 hasLocation W21493314091 @default.
• W2149331409 hasLocation W21493314092 @default.
• W2149331409 hasOpenAccess W2149331409 @default.

• next